Htfg Impuls Finanzierung von StartUps im deutschen Ökosystem

Htgf Impuls

1. Dr. Lena Krzyzak
Hannover Impuls
September 2020
Finance Landscape for Healthcare
Solutions in Germany
HIGH-TECH
GRÜNDERFONDS
Umea, Sweden

2. What do you expect from my presentation?

3. 3
Who are we? And who are you?
HTGF is the most active VC-Investor in Europe
Source: CBInsights

4. 4
Key Facts –We invest within our 3
rd
fund generation
2005
Founded
Volume
€272m
Investors
2011
Founded
Volume
€304m
2017
Founded
Volume
€319.5m
(€109.5m by
business
investors)
Fund I Fund II Fund III
Term 6-year investmentphase, 7-yeardivestmentphase
Focus
Investment type
Value Add Strategic support from investment managers and Hands-on operational support provided by experts and networks
Seedstage(operative start < 1 year)
Up to € 2 million per company
operative start< 3 years
Upto€ 3 million per company
HTGF III

5. 5
We invest in high-tech startups with strong teams and innovative business models
already in their seed stage
1Founded not more than three years ago, „small businesses“ according to EU definition based in or with independent branch office in Germany
Who weinvestin
Strong
teams
in seed
stage
1
Innovative
business
models
High-tech
startups
…throughlifesciences, chemistry& healthcare
…todigital applications& software…
Across industries from hardware, automation, energy…

6. 6
Our investments are flexible and tailor-made
How we invest –
In the seed phase and in later financing rounds
Suitable
forms of investment
Flexible
investment volume
Open
to joint investments
•€0.6m –Average first investment
by HTGF (up to €1m)
•HTGF maximum investment total
of €3m across all financing rounds
•Equity capital according to valuation
or convertible loan without valuation
(incl. acquisition of shares
at nominal value)
•HTGF welcomes joint investments with
other private and/or public investors

7. 7
HTGF in numbers
Capital, know-how and a strong network
Capital
for investments
Know-how
from >2000 transactions
Largest active network
in the industry
€895.5m
across three funds
Financing
from the seed phase
Know-how in
all life cycle phases
Full access to
a strong network
Experts
Investors Industry
Recruitment
pool
Portfolio
Date: 04/09/2020
2355
119
594
1643
0
500
1000
1500
2000
Total Seed Series A, B…Exit

8. 8
We support you from the seed-stage to the exit –
with experience and a broad investors network
>590
Seed-
investments
2
IPOs
109
millionaires
119
Exits

9. 9
Great track record:
millionaires and countless lifetime achievements
Shape the worldMoney, money, money
Developing new modalities to
treat cancer like
Abalos Therapeutics
Helping to shape the energy
transition like our portfolio
company Next Kraftwerke
Revolutionising the world of finance
like our portfolio company Bitwala
Millionaires on
paper
208
Real
millionaires
109
Date: 04/09/2020

10. 10
Scaling with
industrial partners
Growth financing
Hands on support and
strategic guidance provided
by investment professionals
Creating value together:
Up to € 3 million total investment and an efficient network
+
Active network consisting
of way over 2,000 investors
Up to €3m investment
over the entire life cycle
50% of our team have experience
founding start-ups
50% of the team have
a background in tech
100% commitment and passion
from the whole team
+
+
Way over 100 collaborations
between portfolio companies
and Fund Investors
HTGF III Fund Investors

11. 11
Successful events for HTGF network partners
organized one-on-one sessions for
fundraising
Industry representatives
meet HTGF-portfolio companies
Private investors
have invested 305 million €
into the HTGF-portfolio
The Family Day is Germany’s
leading Venture Capital event
with >1,000 participants
>700 one-to-one sessions
to promote cooperations
Exclusive HTGF network of
650 wealthy private investors
Numerous start-ups presenting
their innovative business in
front of Investors
Pitch Days for HTGF’s partners
and related investors
•Chemistry
•Life Science
•Medtech
•Berlin

12. 12Date: 12/06/2020
Business prowess shown on countless occasions:
Our exits
2007 –09
YieldSolutions
SwetOptics
GmbH
2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020

13. At which stage (age) of your company did you decide that
the German market will be interesting for you?

14. Collaboration at early stage
Opportunities in Germany

15. 15
Support programs for university spin-offs
EXIST Gründerstipendiumsupports the preparation of innovative technology-oriented and knowledge-based start-up projects for
students, graduates and scientists.
EXIST Forschungstransferpromotes both necessary development work to prove the technical feasibility of research-based start-up ideas
as well as necessary preparations for the start of the company.
GründungsoffensiveBiotechnologie(GO-Bio): With GO-Bio, start-up science teams from the life sciences are funded for a maximum of
seven years -up to four years before the foundation in the first funding phase and possibly three years after the foundation ina second
funding phase.
KMU Innovativ: Small and medium-sized enterprises (SMEs) are at the forefront of technological progress in many areas. With the
funding initiative KMU-innovativ, the BMBF supports cutting-edge research in German SMEs.
VIP+: The path from research to the market can be shorter and faster. This is where the BMBF funding measure "Validation of the
technological and social innovation potential of scientific research -VIP +" comes into play.
WIPANO -Transfer of knowledge and technology through patents and standardsstarts here: Firstly, the efficient exploitation and use of
intellectual property will enable the economic exploitation of innovative ideas and inventions from public research and the use of
creative potential, in particular small and medium-sized ones Companies (SMEs). On the other hand, the transfer of the latest research
results into standards and standards is encouraged
andotherawards, business-plan competitionsandtechnologytransfersupporters.

16. 16
A few selected Incubators & Accelerators
Healthy.hubprovides an interaction platform for Digital Health Companies to public health insurances.
The BaseLaunchaccelerator is specifically tailored to the needs of healthcare startups. It offers carefully selected ventures non-dilutive
financial support, no strings attached to its healthcare partners. Knowledge from highly experienced advisors, as well as a state-of-the-
art infrastructure. Furthermore, BaseLaunchembeds startups deeply within the Basel region, one of Europe’s finest biotech
ecoysystems.
Johnson & Johnson Innovation has announced the location of its 10th JLABS in Beerse, Belgium, making this the first JLABS in Europe.
Called JLABS @ BE, the site will accommodate up to 30 life science start-ups focused on innovations across the entire healthcare
spectrum, including biotech, pharmaceuticals, medical devices, consumer and healthtechsectors.
Merckselects and supports early-stage start-ups to become ready for the market. Merck sees them as partners that shape the future
together with them. The Merck Accelerator Program of Spring 2018 began in March with new start-ups moving into the new Innovation
Centerin Darmstadt, Germany. Fields of interest: Healthcare, Life Science, Performance Materials and more.
Grants4Appswas founded in 2013 in Berlin initially giving out grants to innovative healthcare apps (hence the name Grants4Apps), it
fast forward to 2018 and beyond, where it is now a global program dedicated to help innovative health & care startupsgrow and enable
positive disruption and progress within the digital health & care universe.
The German Co-Location Centerof EIT Health is supporting German and Swiss EIT Health partners and provides support, skills and
services for startupsand SMEs to boost their business idea.

17. What kind of investor is interesting for you?

18. Funding landscape in Germany

19. 19
Start-up stage and matching investor
Founder
Venture Capital Firms
& Corporate InvestorenBanks
IPO,
Acquisition
Mature
Expansion
Quick growth
Market entry
Prototype
Foundation
Cash Flow
Time

20. 20
Financing Opportunities at different stages
Stage
Duration 5 Years +1-2 Years 3-5 Years 8-10 Years +0,5-2 Years
Start-Up
Incoporation
(Seed)
Pre-Seed Growth Growth +
Funding sources
Goals
Bank loans
Stock market: IPO, capital increase, bonds, etc.
Strategic investors, cooperation partners
ERP-Programs (e.g. start-up fund, fund of funds)
Venture Capital (conventional VC, PIPE)
R&D subsidy programmes
High-Tech Gründerfonds
Regional Seedfunds
Business Angels
Equity capital
Funding programmes offered by German ministry
for education and research, e.g. EXIST founder
grant & research transfer, GO-Bio
Brainstorming
Concept
R&D
Patents
Business plan
(First draft)
Shaping company
structure
Team
Business plan
Tech development
Proof of concept
Tech optimisation
Market preparation
Production stage
Studies
Key clients
Production
Sales
Market share
Cooperation
Licensing
Studies
Internationalisation
Consolidation
Diversification
Portfolio expansion
Acquisitions
Spin-offs
Time

21. 21
Insights into HTGF’s portfolio and funding sources
In more than 1,500 follow-on financing rounds, a total of approx. € 2,478 bnwas raised from various third-party sources
(without HTGF funds) for the portfolio companies
Date: 04/09/2020
20
35
23 23
37 32 31 33
75 72
37
22
14
23
52
69
50
129
86
92
114
64
11
15 25
41
34
41
57
83
85
82
62
6
15
11
26
19
17
74
36
89
80
27
42
15
30
31 26
32
21
23
61
46
20
41
15
11
14 12
15
11
16
20
17
19
18
8
100
124 121
187 190
177
370
301
407
227
0
100
200
300
400
2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Investmentvolumen in Mio. €
inl. VCausl. VCBusiness AngelCorporatesAnleger ÖffentlicheHTGF
Public
Corporate
BA
VCs
German VCs

22. What kind of technology is the focus of your business?

23. 23
Funding landscape in Germany
Private funding
Strategic investors
Business Angels
&
Family Offices
European
Venture Capital funds Directinvestmentsby
strategicpartners(majority:
mid-size orbiggercompanies)
Corporate Venture Capital
Funds
Public funding
Regional Seedfunds
•Sector-specific
input
•Business support
•Mentoring
•Personal network
and „dooropener“

24. 24
580 Portfolio Companies financed
In three funds cycles since 2015
Of which 62 (10,4%) are Med-Tech Companies
4
Our Stats in a nutshell:
Source: https://www.greenlight.guru/blog/top-20-medical-device-venture-capital-firmsPublishedNov. 2018
Date: 29/05/2020
Wearea tech-agnosticfundwitha strong Med-Tech focus
892,5 Mio. € AuM

25. 25
End
High potential
academic
project
Seed Funding Series A
Growth Funding
Series B, C…
Exit!
Working
Prototype
Grants
Case Study: KumovisGmbH
Incorporation of
GmbH
2016
Dream Team
established
2017 August 2018 April 2020
+ Family Office
Kumovis
meets HTGF
Fund Raising →
Collaboration
Kumovis,
HTGF and FO

26. 26
Strong and committed team
>250 yearsofinvestmentexperiencethroughscientists, engineers, economists and lawyers, aswellasformerfounders
Date: 12/06/2020

27. 27
Dr. Lena Krzyzak
[email protected]
[phone]
https://www.linkedin.com/in/lena-krzyzak-419159b4/
Looking forward to get in touch!
high-tech-gruenderfonds.de
Twitter: @HTGF
Facebook: @HTGF.VC
YouTube: HTGF. VC

28. There are many
different waysto
achieve success with us.
We look forward to seeing
you find your own way.
See you
soon
at HTGF!